Given that prior research has demonstrated that H3K18la in senescent microglia contributes to brain aging and Alzheimer's disease by NF-κB activation [37], we aim to investigate whether RPS6KC1 is implicated in the regulation of H3K18la and its potential impact on the inhibition of cellular ferroptosis and Enz resistance. This evidence concerns the gene RPS6KC1 and Alzheimer disease.